@article{JTD20558,
author = {Pascale Tomasini and Laurent Greillier and Arnaud Boyer and Arnaud Jeanson and Fabrice Barlesi},
title = {Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 9},
year = {2018},
keywords = {},
abstract = {Immune Check Point inhibitors (ICIs) have demonstrated efficacy in advanced stage solid tumors including non-small cell lung cancer (NSCLC), CTLA4, programmed cell death-1 (PD-1) and PD-1 ligand 1 (PD-L1) inhibitors being the most studied drugs.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/20558}
}